CIK 0001641281
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472804636
- Phone
- +1 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 1,328 shares at an average $12.93 ($17,175)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 6,256 shares at an average $7.04 ($44,067)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 400,000 shares at $20.00 ($8,000,000)
- 4 Open-market buy 10% owner bought 450,000 shares at $20.00 ($9,000,000)
- 4 Open-market buy 10% owner bought 350,000 shares at $20.00 ($7,000,000)
- 4 Open-market buy Director bought 1,200 shares at $20.00 ($24,000)
- 4 Open-market sale Director sold 62 shares at $20.00 ($1,240)
- 4 Open-market buy Director bought 450,000 shares at $20.00 ($9,000,000)
- 4 Open-market buy Director bought 2,200 shares at $20.00 ($44,000)
- 4 Open-market buy Director bought 200,000 shares at $20.00 ($4,000,000)
Page 6 of 8 · 142 filings